Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

This repository is under review for potential modification in compliance with Administration directives.

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

Development Status

Other

16

US Approved Rx

5

Possibly Marketed Outside US

2

Investigational

1

All Match

Any Match

Exclude Selected

Exclude Selected

Approval Year

Unknown

18

2019

4

1953

1

2021

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Class

Structurally Diverse

24

All Match

Any Match

Exclude Selected

Exclude Selected

Code System

FDA UNII

24

DAILYMED

9

NCBI TAXONOMY

8

WIKIPEDIA

6

RXCUI

5

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 1

ANTIINFECTIVES FOR SYSTEMIC USE

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 2

VACCINES

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 3

VIRAL VACCINES

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 4

Yellow fever vaccines

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Form

Principal Form

23

Salts, Hydrates, Esters, etc.

1

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 21 - 24 of 24 results

First page
Previous page
3
Next page disabled
Next page disabled

HEPATITIS C VIRUS

QI56415283

Status:

Other

Class:

STRUCTURALLY DIVERSE

TICK-BORNE ENCEPHALITIS PURIFIED ANTIGEN (FORMALDEHYDE INACTIVATED)

42XD79UQQ6

Status:

Possibly Marketed Outside US

First approved in 2021

Class:

STRUCTURALLY DIVERSE

YELLOW FEVER VIRUS STRAIN 17D WHOLE

VPK9W87TBS

Status:

Possibly Marketed Outside US

Class:

STRUCTURALLY DIVERSE

HEPATITIS C VIRUS GENOTYPE 3

VRL5MWK6N7

Status:

Other

Class:

STRUCTURALLY DIVERSE

Showing 21 - 24 of 24 results

First page
Previous page
3
Next page disabled
Next page disabled

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1